BMO Capital analyst Andrew Strelzik raised the firm’s price target on Bunge (BG) to $135 from $130 and keeps an Outperform rating on the shares. The company’s investor day presentation was positive as the management laid out a framework to achieve the $15 mid-cycle EPS baseline by 2030, the analyst tells investors in a research note. BMO adds it has come away with greater confidence in Bunge’s multi-year earnings trajectory.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG:
